SEI Investments
NPCE icon

SEI Investments’s Neuropace NPCE Stock Holding History

SEI Investments’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$988K Sell
62,177
-59,299
-49% -$954K ﹤0.01% 2302
2026
Q1 		$1.6M Buy
121,476
+41,233
+51% +$619K ﹤0.01% 2120
2025
Q4 		$1.24M Buy
+80,243
New +$1.07M ﹤0.01% 2081

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

SEI Investments's NPCE Position: Q2 2026 in Review

SEI Investments reduced its Neuropace (NPCE) stake by 49% in Q2 2026, selling an estimated $954K and leaving 62,177 shares worth $988K. The position accounts for ﹤0.01% of the portfolio, ranked #2302.

SEI Investments first reported a position in NPCE in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.6M in Q1 2026. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • SEI Investments held 62,177 shares of Neuropace worth $988K as of Q2 2026.
  • SEI Investments sold 59,299 Neuropace shares in Q2 2026, an estimated $954K.
  • Neuropace made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2302 holding.
  • SEI Investments first reported a position in Neuropace in Q4 2025 and has held it in 3 quarters since.
  • SEI Investments's Neuropace position peaked at $1.6M in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.